Cogstate is a pioneering cognitive science company dedicated to optimizing the measurement of brain health. They provide innovative, technology-based solutions for cognitive assessment in clinical trials, particularly in areas like Alzheimer's disease, as well as tools for earlier clinical insights in healthcare. Their digital platforms and scientific expertise help pharmaceutical and biotech companies accelerate the development of new medicines, and support clinicians in understanding and managing cognitive function. From an end-user perspective, Cogstate's work contributes to faster drug discovery for brain disorders and more informed patient care by providing sensitive and reliable cognitive testing methods.
Serves as the global corporate center, housing executive leadership, finance, strategic planning, and core research and development oversight for Cogstate's worldwide operations.
Modern office facilities within a prominent commercial building in Melbourne's CBD, designed to foster collaboration and innovation.
The work culture at Cogstate's headquarters is science-backed and people-first, emphasizing innovation, quality, and continuous advancement. Employees experience a collaborative environment focused on making a tangible impact on global health through cutting-edge cognitive science.
Melbourne's vibrant biotechnology ecosystem, access to skilled talent, and strong research institutions make it an ideal location for Cogstate's global headquarters, facilitating innovation and international collaboration.
Cogstate globally supports clinical trial services including study design consultation, rater training, data quality monitoring, and the deployment of digital cognitive assessment technologies. They also provide solutions for healthcare settings for early detection and monitoring of cognitive decline, serving clients in numerous countries across North America, Europe, Asia-Pacific, and other regions.
Level 7, 411 Collins Street
Melbourne
VIC
Australia
Address: 195 Church Street, 8th Floor, New Haven, CT 06510
Facilitates Cogstate's engagement with the significant US pharmaceutical and biotech market, supporting clinical trials and client relationships across North America.
Address: Level 9, SVAX Nishi-Shimbashi Building, 2-38-3 Nishi-Shimbashi, Minato-ku, Tokyo 105-0003
Strengthens Cogstate's presence in the Asian market, catering to the specific needs of pharmaceutical research and healthcare providers in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cogstate' leadership includes:
Cogstate has been backed by several prominent investors over the years, including:
Over the past 12 months, Cogstate has seen changes at the Non-Executive Director level aimed at strengthening its board governance. The core C-suite executive team has demonstrated stability during this period.
Discover the tools Cogstate uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cogstate commonly uses the email format consisting of the employee's first initial followed by their last name, all before the '@cogstate.com' domain. While variations might exist for some individuals, this pattern is generally reliable for reaching Cogstate employees.
firstinitiallastname@cogstate.com
Format
boconnor@cogstate.com
Example
85%
Success rate
Cogstate ASX Announcement / Company Website • 2024-02-27
Cogstate reported strong financial performance for the first half of Fiscal Year 2024, highlighting significant revenue growth from clinical trials contracts ($27.1 million, up 46%) and positive operating cashflow. The results underscored continued demand for its cognitive assessment solutions in global clinical trials....more
Cogstate ASX Announcement / Company Website • 2024-05-01
Cogstate released its Appendix 4C quarterly cashflow report for the period ending March 31, 2024, detailing customer receipts of $12.1 million and a net cash increase. The report confirmed ongoing sales momentum in clinical trials and continued investment in product development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cogstate, are just a search away.